[ad_1]
US drugmaker Johnson & Johnson (J&J) said Monday that temporarily halted clinical testing of its COVID-19 vaccine because one of its participants became ill.
The most seen
“We have temporarily halted the administration of new doses in all of our COVID-19 vaccine clinical trials, including the phase 3 ENSEMBLE trial, due to unexplained illness in a study participant,” the company said in a statement.
The pause means that online registrations were closed, while convening the independent patient safety committee.
J&J said that serious adverse effects were “An expected part of any clinical trial, especially a large one.”
See also: They announce a new date for the debate and motion of censure against the Minister of Defense
According to the guidelines, they can stop a study to determine if the side effect was due to your drug and if it can be resumed.
Advertising
Phase three of the Johnson & Johnson study began recruiting volunteers in late September, with the goal of enroll up to 60,000 participants in more than 200 locations in the United States and the world.
See also
The other countries where the tests were performed are Argentina, Brazil, Chile, Colombia, Mexico, Peru and South Africa.
J&J is the tenth laboratory in the world to carry out phase three tests against COVID-19, and the fourth in the United States.
